October 2026 numbers from each country's official database — and why even the January 2027 price cut leaves the US several times higher.
Researched with AI assistance; every figure is checked against the primary source cited on this page before publishing. How we work →
Price of one Ozempic 1 mg pen — four weekly doses, about a month — from each country's official source, converted to US dollars at European Central Bank reference rates of October 20, 2026. The US figure is what pharmacies pay (CMS NADAC), not what an insured patient pays at the counter; the 2027 figures are announced prices that have not taken effect yet. The European figures are each system's official price level — the public price including VAT in Switzerland, the social-insurance price excluding VAT in Austria (a confidential discount applies), the average pharmacy price in the Netherlands. Germany publishes no free official price for Ozempic; it is not on the statutory reference-price (Festbetrag) list.
| Country | Price for one month (1 mg) | In US dollars | What a patient typically pays |
|---|---|---|---|
| 🇺🇸 United States (today) | $995.82 pharmacy cost | $996 | Depends on insurance; $349 cash price from the maker |
| 🇺🇸 United States (from Jan 1, 2027) | $675 list · $274 Medicare | $675 / $274 | Depends on insurance and plan |
| 🇬🇧 United Kingdom | £73.25 NHS price | $98 | Nothing in England with a diabetes medical exemption certificate |
| 🇫🇷 France | €76.58 official price | $86 | 30% reimbursed for type 2 diabetes; the rest depends on the patient's other cover |
| 🇩🇪 Germany | No official price list | — | €5–€10 co-payment for type 2 diabetes (€7.50–€15 from 2027); not covered for weight loss |
| 🇨🇭 Switzerland | CHF 106.20 official public price | $129 | Type 2 diabetes only: franchise, then 10% |
| 🇦🇹 Austria | €104.35 (excl. VAT) | $117 | €7.55 prescription fee; insurer approval needed first |
| 🇳🇱 Netherlands | €107.98 average pharmacy price | $121 | Reimbursed under conditions (type 2 diabetes, BMI 30+); counts against the deductible |
| 🇲🇽 Mexico | Not published | — | Set by each pharmacy |
| Market | Figure | Context | Source |
|---|---|---|---|
| United States — today | $995.82 / pen (pharmacy cost) | CMS's NADAC survey puts the Ozempic 1 mg pen (4 mg/3 mL) at $331.94 per mL as of October 21, 2026 — $995.82 for the pen, which holds one month of weekly doses. The 0.25–0.5 mg and 2 mg pens cost pharmacies the same. That is what pharmacies pay, not what an insured patient pays at the counter. | CMS NADAC (Oct 21, 2026) |
| United States — maker's cash price | $349 / month ($499 for 2 mg) | Novo Nordisk's own self-pay price for patients who pay without insurance: $349 a month for the 0.25 mg to 1 mg doses and $499 for 2 mg. New patients can get a $199 first fill on the starter pen if the prescription is written and received by December 31, 2026. | Novo Nordisk — NovoCare (retrieved Oct 21, 2026) |
| United States — list price from 2027 | $675 / month | On February 24, 2026, Novo Nordisk announced that the US list price of Ozempic, Wegovy and Rybelsus falls to $675 a month for all doses from January 1, 2027 — about 35% lower for Ozempic. The company says self-pay prices are not affected. | Novo Nordisk press release (Feb 24, 2026) |
| United States — Medicare from 2027 | $274 / 30-day supply | The price Medicare negotiated for semaglutide (Ozempic, Rybelsus, Wegovy) under the Inflation Reduction Act, in effect from January 1, 2027. The 2024 list price for the same 30-day supply was $959 — a 71% discount. | CMS negotiated prices, IPAY 2027 |
| France | €76.58 / pen (≈ $86) | France's public medicines database lists the Ozempic 1 mg pen at €76.58 (€77.60 with the dispensing fee); the 0.25 mg and 0.5 mg pens cost the same. Social Security reimburses 30%, and only for type 2 diabetes in specified drug combinations. | BDPM (updated Sep 29, 2026) |
| United Kingdom | £73.25 / pen (≈ $98) | The NHS indicative price for an Ozempic 1 mg pen has been £73.25 since December 2018; the 2 mg pen is £146.50 (since February 12, 2026). In England, people whose diabetes is treated with medication can get a medical exemption certificate and pay nothing for prescriptions. | NHSBSA dm+d · NHSBSA exemptions |
| Mexico | No official price published | Mexican pharmacies set their own prices and no government database publishes them the way France's BDPM or the NHS dm+d does. Online figures come from retailers and vary by pharmacy, dose and date, so we don't state one as fact. | — |
| Estimated production cost | $28–140 / person-year (≈ $2–12 / month) | A 2026 analysis of semaglutide ingredient shipment records (Nov 2024–Nov 2025) estimates generic injectable semaglutide could be produced for $28–140 per person per year. The active ingredient costs about $0.01–0.12 per dose; the disposable pen, $0.30–2.50. An estimate, not a sale price. | Levi et al., Obesity (2026) |
We compare what the medicine costs, not what anyone should take, switch, or stop. Nothing here recommends buying from any pharmacy, seller, or country. Medication decisions belong with you, your pharmacist, and a licensed prescriber.
The number this page and our video led with in June 2026 — about $936 a month — came from list-price tracking dated 2023. In October 2026 the national pharmacy-cost survey puts the same 1 mg pen at $995.82, higher rather than lower. France still pays one official price of €76.58 and the NHS £73.25, a price that hasn't moved since 2018. The NHS does pay more for the newer 2 mg pen (£146.50 since February 2026), where every US dose costs pharmacies the same.
From January 1, 2027, the list price drops to $675 for every dose (Novo Nordisk), Medicare pays its negotiated $274 for a 30-day supply (CMS), and the maker's own cash price — $349 for most doses today — is, by the company's statement, not changed by the list cut. Which number reaches a patient depends on whether they are insured, on Medicare, or paying cash. None of the three is close to the €76.58 France pays today.
The 2026 Obesity analysis puts the active ingredient at roughly one to twelve cents per dose, while the disposable pen device costs $0.30 to $2.50 — the device alone can cost 8 to 68 times more than the ingredient and all other production costs combined. Its estimate of $28–140 per person per year for a generic injectable is an estimate of what production could cost after patent expiry, not a price anyone pays today. Even the high end, about $12 a month, sits far below the $675 list price coming in 2027.
This page began as a US-versus-Mexico comparison. We could not find a neutral, official Mexican retail price — no equivalent of France's BDPM or the NHS dm+d publishes one — so we no longer quote a range. For anyone weighing a purchase abroad, two documented facts matter more than any price: the FDA says it is aware of counterfeit Ozempic marketed in the US, and US rules generally limit personal imports to a 90-day supply with a valid US prescription.
As of October 2026, one Ozempic 1 mg pen — a month of weekly doses — costs US pharmacies $995.82 (CMS NADAC). France's official price for the same pen is €76.58, about $86 (BDPM), and the NHS price is £73.25, about $98 (NHSBSA dm+d). That makes the US pharmacy cost roughly 10 to 12 times the French and British prices.
We could not find an official, published retail price for Ozempic in Mexico. Mexican pharmacies set their own prices, and no government database lists them the way France's BDPM or the NHS dm+d does, so we don't state a number as fact. Two things apply regardless of price: the FDA says it is aware of counterfeit Ozempic marketed in the US, and bringing medication into the US is generally limited to a 90-day personal supply with a valid US prescription.
Yes, on paper. Novo Nordisk announced on February 24, 2026 that the US list price of Ozempic falls to $675 a month from January 1, 2027, and Medicare's negotiated price of $274 for a 30-day supply takes effect the same day (CMS). Even $675 is about 7 to 8 times the French and British prices today. What an individual pays still depends on insurance, pharmacy and coupons.
Novo Nordisk sells Ozempic directly to patients who pay without insurance: $349 a month for the 0.25 mg to 1 mg doses and $499 for 2 mg, with a $199 first fill on the starter pen for new patients whose prescription is written and received by December 31, 2026 (NovoCare, October 2026). Patients using the offer agree not to submit the purchase to an insurer.
A 2026 peer-reviewed analysis in Obesity (Levi et al.), based on semaglutide ingredient shipments from November 2024 to November 2025, estimates generic injectable semaglutide could be produced for $28 to $140 per person per year — about $2 to $12 a month. The active ingredient costs about $0.01 to $0.12 per dose; the disposable pen costs more, at $0.30 to $2.50. That is an estimated production cost, not a market price.
There are documented risks. The WHO issued a global alert on falsified semaglutide in June 2024. As of May 31, 2026, the FDA had received 990 adverse-event reports tied to compounded semaglutide, and it says it is aware of counterfeit Ozempic marketed in the US. FDA and CBP rules generally allow only up to a 90-day personal supply with a valid US prescription. This is information, not medical or legal advice — talk to a licensed provider and pharmacist.
Both are semaglutide, but Wegovy is the weight-loss brand and costs more: four Wegovy 2.4 mg pens cost US pharmacies about $1,307 a month in October 2026 (CMS NADAC). From January 1, 2027 both brands list at $675. Separately, Medicare's GLP-1 Bridge (July 2026 to December 2027) covers Wegovy for weight management at a $245 net price and a $50 copay — Ozempic, a diabetes drug, is not part of it.
Wellness Vision does not sell medication, book trips, or receive referrals. We do not recommend specific pharmacies, sellers, or providers, and we name none. Every figure above traces to a public source: a US government price survey and fact sheet, the manufacturer's own announcements, France's and the NHS's official medicines databases, a peer-reviewed journal, and the FDA and WHO. This is a cost comparison, not medical advice — talk to a qualified, licensed healthcare provider and pharmacist before any decision about medication.
📋 Or get the free Medical Travel Cost Checklist — no email →
View provenance manifest for this video →
You shouldn't have to go broke to feel whole.
